Poland - Vaccines

Description

The subject matter of the order is the supply of D - BLOOD VIACCINE 5 AMP - 0.5ML in a total amount of 260 dosesIn accordance with the description of the subject matter of the order specified in the SWZ and under the conditions specified in the draft provisions of the contract, which are an annex to the SWZ.
The subject of the proceedings is the supply of vaccine for securing the implementation of vaccination in 2023 within the framework of the Immunization Program, i.e.: D - BLOOD VIACCINE 5 AMP - 0.5ML in the number of 260 doses.1. The order must be carried out in accordance with the requirements specified in the SWZZ and PPU.2. Subject evidence:2.1. Pursuant to Article 105 and Article 106 of the PPL Act. in order to confirm the compliance of the offered supplies with the requirements, features or criteria specified in the description of the subject matter of the contract or the criteria for evaluation of tenders or the requirements related to the execution of the contract, the contracting authority shall require the contractors to present:A valid, current marketing authorization for a medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,orA valid, current marketing authorization for a medicinal product issued by the Council of the European Union or the European Commission,2.Pursuant to Article 107 (1) of the PPL Act, the Contractor is obliged to submit the aforementioned means of evidence with the bid and shall exercise all due diligence to ensure that these documents are complete and contain all necessary information to enable the Contracting Authority to verify their correctness.2..3 The Contractor shall be obliged to inform the Contracting Authority of the transfer of the Responsible Party's obligations under the Drug Product Marketing Authorization to another entity.2.4 The marketing authorization for the medicinal product must be valid and current as of the date of submission of bids.2.5 The composition of the preparation and packaging must be consistent with the content of the documents referred to in paragraph 2.1.2.6 In the event that the validity of the document expires, the Contractor is obliged to provide the Ordering Party, together with the documents referred to in paragraph 2.1. an additional document declaring the submission in due3 / 9 time of an application for renewal of the marketing authorization of the medicinal product or, if obtained, a valid marketing authorization of the medicinal product.2.7 The aforementioned documents must have a validity period covering the entire period of performance of the contract.2.8 The documents referred to above shall be submitted in the manner provided for in the regulations issued pursuant to Article 70 of the PPL Act.2.9 The Contracting Authority, pursuant to Article 107(2) of the PPL Act, provides for the possibility of supplementing the aforementioned means of evidence once within the time limit set by the Contracting Authority.2.10 Documents prepared in a foreign language shall be submitted together with a translation into Polish.

Opportunity closing date

24 January 2023

Value of contract

to be confirmed